Anti-GNPTAB monoclonal antibody

Pre-made anti-GNPTAB monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GNPTAB/GNPTAB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0917-Ab-1/ GM-Tg-hg-IP0917-Ab-2Anti-Human GNPTAB monoclonal antibodyHuman
GM-Tg-rg-IP0917-Ab-1/ GM-Tg-rg-IP0917-Ab-2Anti-Rat GNPTAB monoclonal antibodyRat
GM-Tg-mg-IP0917-Ab-1/ GM-Tg-mg-IP0917-Ab-2Anti-Mouse GNPTAB monoclonal antibodyMouse
GM-Tg-cynog-IP0917-Ab-1/ GM-Tg-cynog-IP0917-Ab-2Anti-Cynomolgus/ Rhesus macaque GNPTAB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0917-Ab-1/ GM-Tg-felg-IP0917-Ab-2Anti-Feline GNPTAB monoclonal antibodyFeline
GM-Tg-cang-IP0917-Ab-1/ GM-Tg-cang-IP0917-Ab-2Anti-Canine GNPTAB monoclonal antibodyCanine
GM-Tg-bovg-IP0917-Ab-1/ GM-Tg-bovg-IP0917-Ab-2Anti-Bovine GNPTAB monoclonal antibodyBovine
GM-Tg-equg-IP0917-Ab-1/ GM-Tg-equg-IP0917-Ab-2Anti-Equine GNPTAB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0917-Ab-1/ GM-Tg-hg-IP0917-Ab-2; GM-Tg-rg-IP0917-Ab-1/ GM-Tg-rg-IP0917-Ab-2;
GM-Tg-mg-IP0917-Ab-1/ GM-Tg-mg-IP0917-Ab-2; GM-Tg-cynog-IP0917-Ab-1/ GM-Tg-cynog-IP0917-Ab-2;
GM-Tg-felg-IP0917-Ab-1/ GM-Tg-felg-IP0917-Ab-2; GM-Tg-cang-IP0917-Ab-1/ GM-Tg-cang-IP0917-Ab-2;
GM-Tg-bovg-IP0917-Ab-1/ GM-Tg-bovg-IP0917-Ab-2; GM-Tg-equg-IP0917-Ab-1/ GM-Tg-equg-IP0917-Ab-2
Products NameAnti-GNPTAB monoclonal antibody
Formatmab
Target NameGNPTAB
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GNPTAB monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0917-Ag-1Recombinant multi-species GNPTA/ GNPTAB/ ICD protein


    Target information

    Target IDGM-IP0917
    Target NameGNPTAB
    Gene ID79158,432486,362865,697307,475443,101100231,509610,100067011
    Gene Symbol and SynonymsEG432486,GNPTA,GNPTAB,ICD,RGD1564821
    Uniprot AccessionQ3T906
    Uniprot Entry NameGNPTA_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000111670
    Target ClassificationN/A

    The target: GNPTAB, gene name: GNPTAB, also named as GNPTA, ICD. This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.